223 81 Lund
Who we are
PolarCool AB (publ) is a medical device company that offers a controlled cooling treatment with our patented PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden and the shares are listed on Spotlight Stock Market.
What we do
We focus on treatment of concussive and sub-concussive brain injury with our CE-certified cooling device PolarCap® System. The device is intended as an acute treatment for concussion, as soon as possible after injury.
Why we do it
Concussions can cause long-term effects due to injury. Repeated concussions may increase the risk of early Alzheimers as well as other chronic diseases. With PolarCap® System, we protect the athletes, their clubs as well as the financial losses occurring while an athlete recovers or having to quit the sport altogether.
We protect athletes and sports. PolarCool AB (publ) is a medical device company that offers a controlled cooling treatment with clinically proven effects. We focus on concussive and sub-concussive brain injuries through our patented technique, PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden and the shares are listed on Spotlight Stock Market.
HOW IT WORKS
Sports-related concussions are unique because physical activity can increase body and brain temperature up to 40°C. At this elevated temperature, the brains metabolism is increased. If a concussion is sustained during sports when an athlete has raised brain temperature and thus a raised energy demand, it can lead to exacerbated injury, and an increased risk of long-term problems
PolarCap® aims to reduce the metabolic demand in the brain, when a concussion occurs during sports. By lowering brain temperature rapidly through controlled cooling.
Our mission is to enhance the safety of athletes by reducing the severity of head injuries through cooling. We protect athletes and sports.
The PolarCap® System is a clinically proven technology for treating concussive and sub-concussive brain injury. It is intended to reduce exercise-induced elevated brain temperature to prevent and limit long-term cognitive impairment after brain trauma.
PolarCap® has the Medical Device class IIa for the EU and is CE marked.